Michael Barbella, Managing Editor03.02.21
Zimmer Biomet Holdings Inc.'s Board of Directors is undergoing some changes. Gail K. Boudreaux and Chairman Larry C. Glasscock are leaving the governing body, and a new member is coming aboard.
Glasscock is retiring in May in accordance with the company's mandatory retirement age guidelines. He will be replaced by Zimmer Biomet President/CEO Bryan C. Hanson.
"Through his leadership during his three-year tenure as President and CEO, Bryan has transformed Zimmer Biomet into a stronger leader and innovator in the global medical technology space," said Glasscock. "I and the entire Board of Directors are excited to see how he continues to drive forward the company's mission and deliver even greater growth and value in his appointment as chairman of the Board."
Glasscock has been a member of the company's Board of Directors since its inception in 2001 and has served as non-executive chairman since May 2013. During his tenure as a director, he has also served as a member of the Audit, Corporate Governance, and Compensation and Management Development committees and as chair of the Audit Committee. Glasscock is the retired chairman, president and CEO of Anthem Inc.
"Over the last 20 years, Larry has made tremendous contributions towards helping the company advance our mission and has played an essential role in the overall growth and transformation of our business," said Hanson. "On behalf of the entire Board of Directors and leadership team, I want to extend my deep gratitude to Larry for his exemplary leadership and service as a member of Zimmer Biomet's Board. We have all benefited immensely from Larry's guidance, leadership and mentorship as board chair."
Boudreaux is not standing for reelection at the 2021 annual meeting of shareholders this spring. She has been a member of the Board since 2012, currently serving on the Audit and Corporate Governance committees. She is president and CEO of Anthem Inc.
"The board expresses its sincere gratitude to Gail for her many significant contributions and years of dedicated service to Zimmer Biomet and the company's shareholders," said Hanson.
The company named Christopher B. Begley as Lead Independent Director, and appointed Sreelakshmi Kolli, senior vice president and chief digital officer of Align Technology Inc. as a member of the Board of Directors, effective immediately.
Begley has been a Zimmer Biomet Board member since 2012 and currently serves as chairman of the Quality, Regulatory and Technology Committee and as a member of the Compensation and Management Development Committee. He is the retired chairman and CEO of Hospira Inc., and currently serves as non-executive board chairman of Hanger Inc.
Hanson said, "We are fortunate to have an individual of the caliber of Chris' experience to serve as Lead Independent Director. He is an accomplished business leader with vast healthcare industry and corporate governance experience. Chris provides valuable strategic perspective as a board member, and I look forward to working with him in his new role."
Kolli joined Align Technology in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to vice president, Information Technology in December 2012 and to senior vice president, Global Information Technology in February 2018. Prior to joining Align Technology, she held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco.
Kolli earned a master's degree in computer applications at the National Institute of Technology in Trichy, India, and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.
"The addition of Sree to our Board of Directors comes at a time when Zimmer Biomet is expanding our portfolio of integrated digital and robotic technologies that leverage data, machine learning and artificial intelligence, an area where her extensive experience and expertise will be valuable," said Hanson. "We look forward to Sree's contributions as we continue to drive our strategic initiatives."
Glasscock is retiring in May in accordance with the company's mandatory retirement age guidelines. He will be replaced by Zimmer Biomet President/CEO Bryan C. Hanson.
"Through his leadership during his three-year tenure as President and CEO, Bryan has transformed Zimmer Biomet into a stronger leader and innovator in the global medical technology space," said Glasscock. "I and the entire Board of Directors are excited to see how he continues to drive forward the company's mission and deliver even greater growth and value in his appointment as chairman of the Board."
Glasscock has been a member of the company's Board of Directors since its inception in 2001 and has served as non-executive chairman since May 2013. During his tenure as a director, he has also served as a member of the Audit, Corporate Governance, and Compensation and Management Development committees and as chair of the Audit Committee. Glasscock is the retired chairman, president and CEO of Anthem Inc.
"Over the last 20 years, Larry has made tremendous contributions towards helping the company advance our mission and has played an essential role in the overall growth and transformation of our business," said Hanson. "On behalf of the entire Board of Directors and leadership team, I want to extend my deep gratitude to Larry for his exemplary leadership and service as a member of Zimmer Biomet's Board. We have all benefited immensely from Larry's guidance, leadership and mentorship as board chair."
Boudreaux is not standing for reelection at the 2021 annual meeting of shareholders this spring. She has been a member of the Board since 2012, currently serving on the Audit and Corporate Governance committees. She is president and CEO of Anthem Inc.
"The board expresses its sincere gratitude to Gail for her many significant contributions and years of dedicated service to Zimmer Biomet and the company's shareholders," said Hanson.
The company named Christopher B. Begley as Lead Independent Director, and appointed Sreelakshmi Kolli, senior vice president and chief digital officer of Align Technology Inc. as a member of the Board of Directors, effective immediately.
Begley has been a Zimmer Biomet Board member since 2012 and currently serves as chairman of the Quality, Regulatory and Technology Committee and as a member of the Compensation and Management Development Committee. He is the retired chairman and CEO of Hospira Inc., and currently serves as non-executive board chairman of Hanger Inc.
Hanson said, "We are fortunate to have an individual of the caliber of Chris' experience to serve as Lead Independent Director. He is an accomplished business leader with vast healthcare industry and corporate governance experience. Chris provides valuable strategic perspective as a board member, and I look forward to working with him in his new role."
Kolli joined Align Technology in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to vice president, Information Technology in December 2012 and to senior vice president, Global Information Technology in February 2018. Prior to joining Align Technology, she held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco.
Kolli earned a master's degree in computer applications at the National Institute of Technology in Trichy, India, and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.
"The addition of Sree to our Board of Directors comes at a time when Zimmer Biomet is expanding our portfolio of integrated digital and robotic technologies that leverage data, machine learning and artificial intelligence, an area where her extensive experience and expertise will be valuable," said Hanson. "We look forward to Sree's contributions as we continue to drive our strategic initiatives."
